In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria

Nicolas C. Issa; Mark S. Rouse; Kerryl E. Piper; Walter R. Wilson; James M. Steckelberg; Robin Patel

doi:10.1016/j.diagmicrobio.2003.09.006

In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria

Nicolas C. Issa, Mark S. Rouse, Kerryl E. Piper, Walter R. Wilson, James M. Steckelberg, Robin Patel

Laboratory Medicine and Pathology

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Abstract

The minimum inhibitory concentration and minimum bactericidal concentration of BAL9141 against 150 clinical isolates of gram-negative bacteria were determined and compared to those of cefepime and ceftriaxone. BAL9141 exhibited comparable activity to cefepime and ceftriaxone against Haemophilus influenzae, Klebsiella pneumoniae, and extended-spectrum β-lactamase nonproducing Enterobacter cloacae, and comparable activity to cefepime against Pseudomonas aeruginosa.

Original language	English (US)
Pages (from-to)	73-75
Number of pages	3
Journal	Diagnostic Microbiology and Infectious Disease
Volume	48
Issue number	1
DOIs	https://doi.org/10.1016/j.diagmicrobio.2003.09.006
State	Published - Jan 2004

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/j.diagmicrobio.2003.09.006

Cite this

@article{4d82947f33774de8a80e1913cdbc57f1,

title = "In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria",

abstract = "The minimum inhibitory concentration and minimum bactericidal concentration of BAL9141 against 150 clinical isolates of gram-negative bacteria were determined and compared to those of cefepime and ceftriaxone. BAL9141 exhibited comparable activity to cefepime and ceftriaxone against Haemophilus influenzae, Klebsiella pneumoniae, and extended-spectrum β-lactamase nonproducing Enterobacter cloacae, and comparable activity to cefepime against Pseudomonas aeruginosa.",

author = "Issa, {Nicolas C.} and Rouse, {Mark S.} and Piper, {Kerryl E.} and Wilson, {Walter R.} and Steckelberg, {James M.} and Robin Patel",

year = "2004",

month = jan,

doi = "10.1016/j.diagmicrobio.2003.09.006",

language = "English (US)",

volume = "48",

pages = "73--75",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria

AU - Issa, Nicolas C.

AU - Rouse, Mark S.

AU - Piper, Kerryl E.

AU - Wilson, Walter R.

AU - Steckelberg, James M.

AU - Patel, Robin

PY - 2004/1

Y1 - 2004/1

N2 - The minimum inhibitory concentration and minimum bactericidal concentration of BAL9141 against 150 clinical isolates of gram-negative bacteria were determined and compared to those of cefepime and ceftriaxone. BAL9141 exhibited comparable activity to cefepime and ceftriaxone against Haemophilus influenzae, Klebsiella pneumoniae, and extended-spectrum β-lactamase nonproducing Enterobacter cloacae, and comparable activity to cefepime against Pseudomonas aeruginosa.

AB - The minimum inhibitory concentration and minimum bactericidal concentration of BAL9141 against 150 clinical isolates of gram-negative bacteria were determined and compared to those of cefepime and ceftriaxone. BAL9141 exhibited comparable activity to cefepime and ceftriaxone against Haemophilus influenzae, Klebsiella pneumoniae, and extended-spectrum β-lactamase nonproducing Enterobacter cloacae, and comparable activity to cefepime against Pseudomonas aeruginosa.

UR - http://www.scopus.com/inward/record.url?scp=0842346267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842346267&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2003.09.006

DO - 10.1016/j.diagmicrobio.2003.09.006

M3 - Article

C2 - 14761726

AN - SCOPUS:0842346267

SN - 0732-8893

VL - 48

SP - 73

EP - 75

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

IS - 1

ER -

In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this